TLDR Finasteride is safe for hair loss treatment and doesn't increase high-grade prostate cancer risk.
This document discusses the updated findings on the use of finasteride for male androgenetic alopecia and its potential link to prostate cancer. The studies show conflicting results, but the most recent study suggests that finasteride does not increase the risk of high-grade prostate cancer. The article emphasizes the importance of informing patients of these updated findings when considering the use of finasteride for hair loss treatment. The authors recommend updated counseling for patients with a history of depression or sexual dysfunction. They state that finasteride is a relatively safe and effective treatment for AGA in men.
11 citations,
January 2018 in “International Journal of Trichology” The true incidence of post-Finasteride syndrome is unclear, and more research is needed.
38 citations,
June 2003 in “Journal of Investigative Dermatology Symposium Proceedings” Finasteride effectively improves hair growth and slows hair loss in men with male pattern baldness.
29 citations,
September 2014 in “Current Opinion in Endocrinology, Diabetes and Obesity” Finasteride and dutasteride effectively treat hair loss in men and women, but may cause side effects like low libido and depression.
1 citations,
August 2015 in “Current Sexual Health Reports” 5α-reductase inhibitors can cause serious and possibly lasting sexual and psychological side effects.
30 citations,
September 2016 in “BMJ” Taking 5-α reductase inhibitors for prostate enlargement or hair loss does not significantly raise the risk of erectile dysfunction.
6 citations,
January 2020 in “Dermatology” Finasteride may increase suicide risk; more research needed.
20 citations,
August 2018 in “The World Journal of Men's Health” Finasteride may increase erectile dysfunction risk in patients with benign prostatic hyperplasia.
